Cape Investment Advisory, Inc. 10x Genomics, Inc. Transaction History
Cape Investment Advisory, Inc.
- $256 Billion
- Q4 2024
A detailed history of Cape Investment Advisory, Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Cape Investment Advisory, Inc. holds 50 shares of TXG stock, worth $529. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$529
Previous $1.13 Million
36.4%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TXG
# of Institutions
302Shares Held
96.5MCall Options Held
76.4KPut Options Held
132K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.9MShares$126 Million1.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$116 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$67.7 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.71MShares$60.5 Million0.06% of portfolio
-
Nikko Asset Management Americas, Inc.5.71MShares$60.5 Million0.92% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.01B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...